Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push
By Christy Santhosh and Sriparna Roy (Reuters) -Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion,…
By Christy Santhosh and Sriparna Roy (Reuters) -Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion,…